Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a

Jimmy T Efird1,2,3,4,5, Andy C Kiser1,2, Patricia B Crane1,3,4

  • 1Center for Epidemiology and Outcomes Research, East Carolina Heart Institute, Greenville, North Carolina.

Pharmacotherapy
|January 5, 2017
PubMed

Insights

Perioperative inotropic therapy (PINOT) is disproportionately linked to postoperative atrial fibrillation (POAF) in black patients undergoing coronary artery bypass graft (CABG) surgery. This racial disparity warrants further investigation into underlying mechanisms.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Electrophysiology
  • Health Disparities Research

Background:

  • Postoperative atrial fibrillation (POAF) increases mortality after coronary artery bypass graft (CABG) surgery, particularly in Black patients.
  • Perioperative inotropic therapy (PINOT) has been previously associated with POAF.
  • The influence of race on the association between PINOT and POAF remains unclear.

Purpose of the Study:

  • To investigate the relationship between perioperative inotropic therapy (PINOT), race, and the incidence of postoperative atrial fibrillation (POAF) in patients undergoing CABG.
  • To determine if race modifies the association between PINOT and POAF.

Main Methods:

  • Analysis of clinical records from a prospectively maintained cohort of 11,855 patients undergoing primary isolated CABG.
  • Log-binomial regression was used to compute relative risks (RR) and 95% confidence intervals (CIs).

Main Results:

  • The association between PINOT and POAF was significantly higher in Black patients (adjusted RR 1.7, CI 1.4-2.0) compared to White patients (adjusted RR 1.3, CI 1.2-1.4).
  • A statistically significant interaction (p=0.013) indicated that race modifies the PINOT-POAF association.

Conclusions:

  • Perioperative inotropic therapy (PINOT) may be disproportionately associated with postoperative atrial fibrillation (POAF) in Black patients undergoing CABG.
  • Further research is necessary to elucidate the mechanisms behind this observed racial disparity.
Abstract

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
491
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
558
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
361